Stelvio HealthCare
- Company typePrivate
- Founded2019
- HeadquartersAhmedabad, India
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
Stelvio HealthCare firmographics
Firmographics- Name
- Stelvio HealthCare
- Legal name
- Stelvio Health Care
- Website
- https://stelviohealthcare.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Stelvio HealthCare industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)
- akta.pro secondary industries
- Cardiology & Vascular Specialty Pharmaceuticals (HLAIACAG), Pulmonology & Allergy Specialty Pharmaceuticals (HLAIACAF), Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity) (CRADAGAE)
Keywords
Where Stelvio HealthCare is headquartered
LocationHeadquarters
- HQ city
- Ahmedabad
- HQ country
- India
- HQ region
- Asia
Offices3 records
Markets served
Stelvio HealthCare business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Technology or R&D, Personnel, Marketing or Sales, Supply Chain
Revenue model
- Branded Formulations: Manufacturing and marketing of branded formulations with differentiation among competitors. Focus on enabling customers to market products under their own brand for better promotion and positioning.
- Generic Medicines: Cost-effective generic medicines for mass requirements across many geographies, providing affordable and accessible health treatment to patients.
- Contract Manufacturing: Manufacturing services for various dosage forms including oral solids, injectables, oral liquids, nutraceuticals, and cosmeceuticals for pharmaceutical companies.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels3 records
Stelvio HealthCare product offering
Product offeringCore offering
Stelvio HealthCare is an R&D-driven pharmaceutical organization that manufactures and markets formulations through a WHO GMP accredited facility in Ahmedabad, India. The company produces solid orals, injectables, oral liquids, nutraceuticals, and cosmeceuticals across therapeutic segments including cardiovascular, antibiotic, NSAIDs, anti-malarial, anti-retroviral, gastro, respiratory, anti-diabetics, anthelmintic, women's wellness, and neuro psychiatric. It supplies both branded and generic formulations to international business partners and pharmaceutical customers.
Product overview
Stelvio HealthCare is an R&D-driven pharmaceutical organization engaged in the manufacturing and marketing of formulations for global patients. The company operates through WHO GMP accredited manufacturing facilities in Ahmedabad, India, producing diverse dosage forms including Solid Oral (tablets, capsules), Injectables (liquid injections, lyophilized vials, ampoules), Oral Liquids (suspensions, oral drops), Nutraceuticals (sachets, effervescent tablets), and Cosmeceuticals (creams, ointments, gels). Their product portfolio spans multiple therapeutic areas including Cardiovascular, Antibiotic, NSAIDs, Anti-Malarial, Anti-retro viral, Gastro, Respiratory, Anti-Diabetics, Anthelmintic/Anti-Parasitic, Women's Wellness, and Neuro Psychiatric. They offer both branded formulations for differentiated positioning and cost-effective generics for mass populations across international markets.
Differentiator
Problem solved
Functional benefit
Companies that use Stelvio HealthCare
Customer profileSegments3 records
Ideal customer profiles3 records
Stelvio HealthCare technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Stelvio HealthCare partnerships and signals
Strategic signalScale indicators3 records
Recent moves5 records
Expansion highlights5 records
Stelvio HealthCare competitors and assessment
Company assessmentDirect peers
- Granules India: Indian pharmaceutical manufacturer focused on oral solid dosages (tablets, capsules), APIs, and Finished Dosage Formulations with strong international customer base — directly comparable in dosage form focus and export-led business model.
- Ipca Laboratories: Indian mid-sized pharma manufacturer with focus on anti-malarials, NSAIDs, anti-hypertensives, and contract manufacturing — closely matches Stelvio's therapeutic mix and contract manufacturing orientation.
Broad incumbents
- Aurobindo Pharma: India-headquartered generic and branded pharmaceutical manufacturer with global export footprint across multiple dosage forms and therapeutic areas — directly comparable business model to Stelvio but at vastly greater scale.
- Cipla: Indian pharma major with strong presence in respiratory, anti-retroviral, and other therapeutic categories where Stelvio also operates, plus significant branded generics franchise across emerging markets.
- Torrent Pharmaceuticals: Indian pharma company with branded and unbranded generics portfolio across cardiovascular, gastro, anti-diabetics, and other therapeutic areas where Stelvio also operates.
- Zydus Cadila (Cadila Healthcare): Indian integrated pharma player spanning formulations, APIs, biologics, and consumer wellness — comparable multi-vertical, multi-dosage-form model with strong export business.
- Glenmark Pharmaceuticals: Indian-headquartered pharma company with branded generics, APIs, and specialty products across respiratory, dermatology, and other segments — comparable multi-therapeutic export orientation.
- Sun Pharmaceutical Industries: India's largest pharma company, manufacturing generics, branded formulations, and APIs with extensive international presence — same horizontal multi-therapeutic, multi-dosage approach as Stelvio, executed at much larger scale.
- Dr. Reddy's Laboratories: Indian pharma company with global generics, branded generics, and contract manufacturing businesses, including injectables — closely aligned with Stelvio's dosage form breadth and B2B export model.
- Lupin Pharmaceuticals: India-based generics manufacturer with multi-therapeutic portfolio and strong international presence, particularly in emerging markets — comparable export-led B2B positioning.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Stelvio HealthCare social profiles
Digital presenceStelvio HealthCare compliance and trust
Trust signalCompliance3 records
Stelvio HealthCare financial estimates
Financial estimateRevenue estimate
Valuation estimate
Stelvio HealthCare leadership team
Management profileNumber of profiles
Profiles4 records
Stelvio HealthCare funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Stelvio HealthCare M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Stelvio HealthCare
What does Stelvio HealthCare do?
Stelvio HealthCare is an R&D-driven pharmaceutical organization that manufactures and markets formulations through a WHO GMP accredited facility in Ahmedabad, India. The company produces solid orals, injectables, oral liquids, nutraceuticals, and cosmeceuticals across therapeutic segments including cardiovascular, antibiotic, NSAIDs, anti-malarial, anti-retroviral, gastro, respiratory, anti-diabetics, anthelmintic, women's wellness, and neuro psychiatric. It supplies both branded and generic formulations to international business partners and pharmaceutical customers.
Is Stelvio HealthCare a public or private company?
Stelvio HealthCare is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Stelvio HealthCare founded?
Stelvio HealthCare was founded in 2019. It employs 1 to 10 people.
Where is Stelvio HealthCare based?
Stelvio HealthCare is headquartered in Ahmedabad, India, in the Asia region.
How does Stelvio HealthCare make money?
Three revenue lines are on record. Branded Formulations are the primary driver. The others are generic Medicines and contract Manufacturing.
Who are Stelvio HealthCare's main competitors?
Direct peers on record are Granules India and Ipca Laboratories. Broad incumbents are Aurobindo Pharma, Cipla, Torrent Pharmaceuticals, Zydus Cadila (Cadila Healthcare), Glenmark Pharmaceuticals, Sun Pharmaceutical Industries, Dr. Reddy's Laboratories and Lupin Pharmaceuticals.
Does Stelvio HealthCare have an API?
No public API is recorded for Stelvio HealthCare.
What industry is Stelvio HealthCare in?
Stelvio HealthCare's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIAAAA, Primary Care & General Medicine Pharmaceuticals, with a secondary code of HLAIACAG, Cardiology & Vascular Specialty Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.